Skip to main content
. 2019 May 24;20(10):2557. doi: 10.3390/ijms20102557
AD-MSCs adipose tissue-derived mesenchymal stem cells
ARD absolute risk difference
BMD bone mineral density
BM-MSC bone marrow-derived mesenchymal stem cell
BMP bone morphogenetic protein
BP bisphosphonate
CI confidence interval
DKK dickkopf
ES embryonic stem
FDA US Food and Drug Administration
iPS induced pluripotent stem
iPSC-MSCs iPS cell-derived MSCs
LRP lipoprotein receptor-related protein
MSCs mesenchymal stem cells
OR odds ratio
OPG osteoprotegerin
PTH parathyroid hormone
RCT randomized controlled trial
RR relative risk
Runx2 runt-related transcription factor 2
RANKL receptor activator of nuclear factor κB ligand
SERM selective estrogen receptor modulator
siRNA small interfering RNA
WMD weighted mean differences